UK Price Scheme Changes To Cost Pharmaceutical Industry £33m

 
• By Ian Schofield
  
Coins
The UK NHS is expected to reap savings from changes to the statutory pricing scheme
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Pricing Debate

More from Market Access